Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study

BMJ Open. 2022 Nov 22;12(11):e062463. doi: 10.1136/bmjopen-2022-062463.

ABSTRACT

OBJECTIVE: To develop a vocal biomarker for fatigue monitoring in people with COVID-19.

DESIGN: Prospective cohort study.

SETTING: Predi-COVID data between May 2020 and May 2021.

PARTICIPANTS: A total of 1772 voice recordings were used to train an AI-based algorithm to predict fatigue, stratified by gender and smartphone's operating system (Android/iOS). The recordings were collected from 296 participants tracked for 2 weeks following SARS-CoV-2 infection.

PRIMARY AND SECONDARY OUTCOME MEASURES: Four machine learning algorithms (logistic regression, k-nearest neighbours, support vector machine and soft voting classifier) were used to train and derive the fatigue vocal biomarker. The models were evaluated based on the following metrics: area under the curve (AUC), accuracy, F1-score, precision and recall. The Brier score was also used to evaluate the models' calibrations.

RESULTS: The final study population included 56% of women and had a mean (±SD) age of 40 (±13) years. Women were more likely to report fatigue (p<0.001). We developed four models for Android female, Android male, iOS female and iOS male users with a weighted AUC of 86%, 82%, 79%, 85% and a mean Brier Score of 0.15, 0.12, 0.17, 0.12, respectively. The vocal biomarker derived from the prediction models successfully discriminated COVID-19 participants with and without fatigue.

CONCLUSIONS: This study demonstrates the feasibility of identifying and remotely monitoring fatigue thanks to voice. Vocal biomarkers, digitally integrated into telemedicine technologies, are expected to improve the monitoring of people with COVID-19 or Long-COVID.

TRIAL REGISTRATION NUMBER: NCT04380987.

PMID:36414294 | DOI:10.1136/bmjopen-2022-062463